Human papillomavirus knowledge, beliefs, and behaviors : a questionnaire adaptation by Horvath, Jaqueline Driemeyer Correia et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology 230 (2018) 103–108Full length article
Human papillomavirus knowledge, beliefs, and behaviors: A
questionnaire adaptation
Jaqueline D.C. Horvatha,*, Natália L. Kopsa, Juliana Caierãob, Marina Bessela,
Glaucia Hohenbergera, Eliana M. Wendlanda,c
aHospital Moinhos de Vento, Porto Alegre, Brazil
bAnalisys Department, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
cCommunity Health Department, Federal University of Health Science of Porto Alegre, Porto Alegre, Brazil
A R T I C L E I N F O
Article history:
Received 15 June 2018
Received in revised form 6 September 2018





A B S T R A C T
Objective: This study aims to adapt a questionnaire about the knowledge, beliefs and behaviors regarding
HPV and related subjects into Brazilian Portuguese.
Study Design: National Survey.
Methods: The instrument was translated into Portuguese and retranslated into English separately. Experts
assessed the validity of the content and cross-cultural adaptation of the instrument. The instrument was
administered to 8580 male and female Brazilian adolescents and young adults (aged between 16 and 25
years) who participated in the National Survey of Human Papillomavirus Prevalence (POP-Brazil). This
large-scale survey enrolled participants from 26 Brazilian capitals and the Federal District.
Results: The full questionnaire is composed of 30 questions, with a good absolute agreement between its
two halves (61.16  9.97). The preventive behavior section showed the lowest agreement. Men and
women showed a difference concerning their knowledge about HPV (score for men 0.48 ( 8.93) vs.
women 0.55 ( 4.51), p < 0.001).
Conclusion: The proposed questionnaire is the first instrument able to describe the knowledge, beliefs and
behaviors regarding HPV and related subjects in Brazilian women and men. This questionnaire appears to
be adequate for use in future studies that may produce evidence and knowledge on these specific topics.
© 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The vaccine against human papillomavirus (HPV) is an effective
and safe method to prevent HPV infections and consequent HPV-
related cancers [1–3]. Persistent infection with high-risk HPV types
is the primary cause of cervical cancer, one of the most common
cancer in women around the world [4]. Furthermore, high-risk
HPV infections are also linked with anogenital (vulvar, vaginal,
penile and anal) and head and neck cancers [4–7]. HPV infections
are the most common sexually transmitted disease in the United
States, with approximately 14 million new genital infections
related to HPV each year [8]. There is no nationwide data on HPV
prevalence in Brazil, but some regional data and a systematic
review shows a prevalence varying from 10.4 to 24.5 in women [9]
and around 60% in men [10].* Corresponding author at: Hospital Moinhos de Vento: Ramiro Barcelos, 910,
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4.0/).Clinical trial results show that the vaccine against HPV is safe
and very effective at preventing infections, in the first years vaccine
introduction, more than 40 countries have implemented national
vaccination programs against HPV [11]. Nowadays, although
vaccination is implemented in more than 80 countries [12], many
places continue to report relatively low coverage [3,13–15] and was
not yet implemented in many lower income countries, who have
populations with the higher cervical cancer incidence rates [12].
Brazil began providing a quadrivalent HPV vaccine (HPV types 6,11,
16 and 18) at schools in 2014 through the National Public Health
System, with coverage near 93% in 2014; however, there was a
marked decline in coverage in the following year (only 41.1% for the
first dose) [16,17].
Stokley et al showed that the most common cause of no
vaccination among female adolescents in the United States of
America was a lack of knowledge about the HPV vaccine [18]. This
lack of information can also be seen with parents and guardians
and is negatively associated with compliance with vaccination. The
lack of recommendation and lack of HPV awareness and
knowledge is recognized the different stakeholders as parents, under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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even so the adolescents as the mains causes of HPV vaccine refuses
[19–21]. Adolescents also reported concerns related to the cost,
potential side effects, vaccination age, perceived needs and fear of
injections [22,23]. Therefore, describing adolescents’ attitudes and
knowledge about the risks associated with HPV infection and
acquisition should be a priority, since sexual activity is an
important determinant of sexual infections [17], especially during
the transition to adulthood.
For this reason, developing an instrument that accurately
measures the young person’s knowledge about HPV is fundamen-
tal to better understand behavior and to provide information to
develop effective prevention programs and campaigns to encour-
age HPV vaccination. Thus, the objective of this study is to adapt a
questionnaire that evaluates the knowledge, beliefs and behaviors
regarding HPV, HPV vaccinations and Pap tests of Brazilian
adolescents and young adults.
Material and methods
We conducted a multicenter, national survey of Brazilian
sexually active adolescents and young adults, aged 16–25 years,
who used the public health system in 26 Brazilian capitals and the
Federal District. The data were collected by trained health
professionals, in primary care units, between 2016–2017. Briefly,
the participants were recruited using different approaches such as
list of patients, clinic visits, domiciliary visits, and school-based
educational health programs. The sampling was distributed
equally in all Brazilian regions to allow a greater variability and
were weighted during analysis. More details about the study
protocol were previous published [24].
Original questionnaire description
The original questionnaire [25] was developed to Italian
population and included 24 items in three sections: 1) knowledge
about HPV, diseases related to HPV infections and vaccination; 2)
Pap tests and the gynecologist-patient relationship; and 3)
sociodemographic data. The Cronbach’s alpha value of this
instrument was 0.774.
Cross-cultural adaptation
For cross-cultural adaptation, two bilingual recognized doctors
with expertise in this subject initially translated the instrument
into Portuguese. A bilingual professional, blind to the original
version, performed a back-translation to English, independently. To
reach the final version, the expert team assessed the content
validity.
We performed a pretest and a pilot. The pretest was conducted
with a small group of students (n = 30) and provided data about the
grammar and difficulty of the questions; this process helped
identify problematic items and the understanding of questions.
The pilot evaluation (n = 200) provided information about vocabu-
lary and allowed the cross-cultural adaptation for all regions of
Brazil (southern, southeastern, central-west, northeastern, and
northern). Primary health care professionals of all regions also give
feedback about the content and vocabulary.
Content adaptation
We evaluated the operational equivalence, the format of the
questions and the application form. Recognized doctors with
expertise in this subject conducted this step. We also analyzed the
clarity of the language, practical relevance and theoretical
relevance; in addition, we included questions considered relevantto a Brazilian population. Finally, we analyzed the whole
questionnaire using a methodology similar to previous question-
naire-adaptation studies [26,27].
Statistical analysis
Data entered into an online database were analyzed using SAS
software (Statistical Analysis System, SAS Institute Inc., Cary, N.C.),
version 9.4, and statistical significance was defined as p < 0.05. We
adjusted the sample size of the study by the distribution of the
population size in each capital and by sexual gender.
Descriptive analyses were performed using percentages and
frequencies, and we created a score (range 0–14 for men and 0–16
for women) that recategorized the variables as dichotomic
measures (adequate and not adequate answers). The difference
between men's and women's scores was because men did not
answer questions related to Pap smears. In this scoring system,
questions about sexual behaviors, attitudes or beliefs, and socio-
demographic factors were not included, creating a total of 16
questions.
To evaluate the construct validity, instead of analyze differences
in two relevant groups [28], we split the total sample in two
random halves [29], assuming that the standard deviations
between two halves were equal and highly correlated [30]. The
median age between two halves was equal (p = 0.8423, indepen-
dent t-test), and we used this variable to assure the groups were
comparable. To analyze the absolute agreement by gender, we first
categorized the sample by gender and then split the full sample
randomly in two halves. The interpretation of the magnitude of the
concordance estimators is normally agreed to be as follows: 0
(absence), 0–19% (poor), 20%–39% (weak), 30–59% (moderate), 60–
79% (substantial/good), and  80% (strong) [31,32].
The study protocols were approved by the Research Ethics
Committee of the Hospital Moinhos de Vento of Porto Alegre and
followed the standards of Resolution 466/12 of the National
Council for research involving humans. All individuals were
informed about the research objectives and confidentiality of
the data and provided written consent.
Results
Content adaptation
The full version of the questionnaire consists of four sections.
The first section includes items about HPV, the second is composed
of questions about sexual behavior, the third is composed of
questions about Pap tests and was exclusively used for women, and
the last is a social demographic profile; the comparative among
original questionnaire and the POP-Brazil questionnaire is at
Appendix 1. An important goal in designing a questionnaire is
maintaining the respondent's compliance and interest [33].
Therefore, highly relevant questions were placed at the beginning
of the questionnaire, and embarrassing or sensitive questions were
placed at the end (Appendix 1).
In content adaptation, we had removed six questions. The
question “Who should provide the vaccine against HPV?”, because
at Brazil the vaccine was already provided by the Brazilian Public
Health System. The question “How often do you have sexual
intercourse?” was replaced by “How many people did you have sex
with in the last 12 months?”. The question “During pap test, are
you satisfied with the communicative aspects with your gynecol-
ogist?” was excluded because at Brazil, general physician or nurse
can also do the test. Some socio demographics factors, as Father’s
and mothers profession and religion were replaced for questions
usually used in Brazilian questionnaires to evaluate income and
social class [34].
Table 1













500 ty 750 dollars 40.33
> 750 dollars 18.50
Education level n (%)
Primary (some or complete) 1.815 (24.56)
Secondary (some or complete) 4.783 (57.43)
University level or higher 1.726 (18.01)
Age n (%)
16–17 years 1.086 (14.14)
18–19 years 1.906 (20.92)
20–21 years 1.895 (21.52)
22–23 years 1.823 (21.60)
24–25 years 1.870 (21.82)
The table shows the results of sociodemographic characteristic. 1Self-defined.
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with HPV vaccination and attitudes as: “Do you believe that a
person infected with HPV necessarily presents with signs and
symptoms?”, “Have you had the HPV vaccine?", “You have not had
the HPV vaccine because . . . . :”, “When you have sexual relations,
do you and your partner use any contraceptive method?”, and
“Have you ever had any changes in Pap smear results?”.
Score analyses and absolute agreement
We assessed data from all participants who were able to finish
the interview (98.15%), a total of 8580 participants. Sociodemo-
graphic results are shown in Table 1.
To analyze the knowledge, we used the score previously
reported. Men and women showed several differences in their
knowledge about HPV. Women were more often correct about the
relation between HPV and cervical cancer but at same time were
more often wrong about the relation between HPV and cystitis.
Men showed more adequate preventive behavior, such as using
condoms, than women (Table 2). In general, neither men nor
women knew about the relation between HPV and esophageal
cancer.
More than half of the participants answered at least 50% of
questions correctly, and only 77 participants did not provide any
correct answers (Fig. 1). Although men showed more adequate
answers in some sections, in general, women presented better
scores (men 0.48 ( 8.93) vs. women 0.55 ( 4.51), p < 0.001).
The mean absolute agreement between the split data from the
Pop-Brazil V6 was 61.16 ( 9.97). The question “In case you are
vaccinated for HPV, what would be your attitude towards the Pap test”
showed the highest absolute agreement at 87.37% (Table 3). The
preventive behavior section showed the lowest agreement values.
Discussion
This study is the first to assess the knowledge, beliefs and
behaviors regarding HPV throughout Brazil, and the first aimed atTable 2
Adequate answers by gender - POP-Brazil V6 score.
Questions 
HPV infection and presence some symptom 
Which of the following diseases






Irritable bowel syndrome 
Anus cancer 
Mouth cancer 
Vaccine and HPV Have you known about HPV vaccination? 
When do you believe the HPV vaccine should
Who should be vaccinated? 
Preventive Behavior When you have sexual relations, do you use a
Did you or your partner use a condom in the la
Pap Test and HPV Do you know Papanicolaou test? 
After Vaccine what would be the attitude
towards the Pap smear?
The table shows the questions include in the score (range 0–14 for men and 0–16 for wom
adequate answers). The perceptual in each question corresponds to the percentage of 
recommendation gender for the vaccine in Brazil has changed during the study. The vaensuring that a questionnaire about HPV adapted for our
population has the same properties and functions as the original
questionnaire. We used a large sample size, including young men
and women of all Brazilian capitals, making the results valid for
both sexes.
We consider values of agreement relevant because the
magnitude of the acceptable difference between scores is not
solely a statistical decision but also a clinical one, meaning that the
acceptable difference depends on the purpose of the test. This
questionnaire intended to describe concepts about sexual diseases.
These ideas are difficult to measure because they depend on a






YES 19.40 17.42 0.1846
YES 62.30 78.80 <0.001*
NO 73.57 67.71 0.0015*
YES 64.89 64.60 0.8819
NO 63.83 58.34 0.0059
NO 55.26 49.89 0.0076
YES 49.03 48.72 0.8765
YES 54.27 55.97 0.3937
YES 68.56 83.06 <0.001*
 be had? Before first intercourse 63.08 66.93 0.0773
Boys and Girls1 89.00 82.57 <0.001*
 condom? YES 54.24 49.32 0.0106
st intercourse? YES 44.73 37.42 0.0002*




en). The variables were recategorized like a dichotomic measure (adequate and not
correct answers according to score, range (0–100%) for men and for women. 1The
ccine initially was just for girls, changing for girls and boys later.
Fig. 1. Participants who answered the Pop-Brazil V6 correctly.
The figure shows the number of participants who answered correctly the questions in Pop-Brazil V6 following the score. The variables were recategorized like a dichotomic
measure. The horizontal axis corresponds to the number of correct answers according score (range 0–14 for men < and 0–16 for women ,). The vertical left axis corresponds to
number of participants; the vertical right axis corresponds to perceptual of participants with adequate answers, the columns are plotted in right axis.
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talking about sex with teenagers and young adults is taboo [35,36],
which could impact the results.
The preventive behavior section presented the lowest agree-
ment, and this result was expected since the absolute agreement
was determined based on independent participants, and this
section comprises questions that have subjective and personal
values. The question with the highest agreement was also the
question with the lowest number of correct answers. The
participants did not recognize the association between esophagealTable 3
Absolute agreement between two halves from the Pop-Brazil V6.
Questions 
HPV infection and presence some symptom 
Which of the following diseases do






Irritable bowel syndrome 
Anus cancer 
Mouth cancer 
Vaccine and HPV Have you known about HPV vaccination? 
When do you believe a HPV vaccine should be
Who should be vaccinate? 
Preventive Behavior When you have sexual relations do you use co
Did you or your partner use condom in the la
intercourse?
Pap Test and HPV Do you know Papanicolaou test? 
After Vaccine what would be attitude towards
Pap smear?
The table shows the absolute agreement in Pop-Brazil V6 following the questions from th
like a dichotomic measure (adequate and not adequate answers) for created the score.
absolute agreement per gender, first we categorize the sample according gender and tcancer and HPV, reflecting a lack of knowledge about this specific
topic. When we assessed differences in knowledge between
genders, women showed more correct answers than men; this
is likely because women are the primary focus of HPV vaccination
efforts [37,38] and because cervical cancer is strongly correlated
with HPV and the first cancer to be associated with HPV infections
[39]. Although more women than men knew about the HPV
vaccine, women indicated fewer preventive behaviors, reporting
less condom use compared to other populations [40]. Knowledge
















 had? 55.88 52.63 56.02
71.71 75.75 70.98
ndom? 52.95 53.01 51.22
st 52.99 47.79 53.11
73.78 – 73.78
 the 87.37 – 87.37
e score (range 0–14 for men and 0–16 for women). The variables were recategorized
 The absolute agreement was obtained from two halves from total sample. For the
hen split the in two halves for obtain the agreement.
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analysis is needed.
Previous studies that have evaluated knowledge about HPV in
Brazilian populations have restrained their samples to specific
populations such as students [42–47], women [48–52] or
healthcare professionals [53]. It is also important to note that
mostly of these previous studies did not use validated instru-
ments [43–47,54]. This use of a validated instrument is consid-
ered a major weakness by Manoel et al [53], who have previously
adapted a questionnaire [55] but used a small female sample in
one Brazilian city. Although there are different questionnaires to
evaluate HPV [23,25,44–54], we chose the one developed by
Saulle et al [25] because it combines sexual behavior, and
knowledge about HPV, vaccine and Papanicolaou test in a short
interview.
The majority of the results from questionnaires show that
knowledge about HPV is “inadequate or insufficient” [58]. A review
of studies performed in college-aged women showed that
participants had a lack of information about HPV and the HPV
vaccine [59]. Several other studies have reported similar results
[33–45]. In this questionnaire, we decided to not classify the
degree of knowledge as sufficient or insufficient because this is a
subjective concept. Like other studies, our data identified a lack of
basic knowledge and understanding regarding HPV and several
specific points [33–35] but a greater recognition of the Papani-
colaou test as a useful screening tool for cervical cancer.
Comparing the current results with those found in the original
article [25], we found that participants had more knowledge
regarding the diseases associated with HPV but less knowledge
about vaccinations. These differences can be explained by the
differences in sampling profiles, as Saulle et al. [25] included a
sample of Italian university women.
It is important describe that this study has some weakness points,
as we did not performance any classical measure for available internal
consistencyasCronbach'salpha.However, it isprudentremindingthat
Cronbach's alpha has some limitations and the assumption for use
Cronbach's alpha was not adequacy for this sample [60,61].
The importancethis studyis because the HPV isstronglyassociated
with several types of cancer, and increasing public awareness of HPV
should be a priority public health issue to encourage better preventive
behaviors. Knowledge is a key point in increasing vaccination rates,
and healthcare providers play a major role in providing information
about HPV prevention for younger patients and parents. Identifying
the gaps and the most vulnerable populations are major issues in
maximizing educational interventions.
Conclusion
The proposed questionnaire is the first instrument able to
describe the knowledge, beliefs and behaviors regarding HPV of
Brazilian women and men. The use of validated instruments allows
comparisons between different populations and over time.
Appendix A. Supplementary data
Supplementary material related to this article can be found, in
the online version, at doi:https://doi.org/10.1016/j.
ejogrb.2018.09.023.
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